Guided Therapeutics Inc
Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. Th… Read more
Guided Therapeutics Inc (GTHP) - Total Assets
Latest total assets as of September 2025: $903.00K USD
Based on the latest financial reports, Guided Therapeutics Inc (GTHP) holds total assets worth $903.00K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Guided Therapeutics Inc - Total Assets Trend (2017–2024)
This chart illustrates how Guided Therapeutics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Guided Therapeutics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Guided Therapeutics Inc's total assets of $903.00K consist of 86.9% current assets and 13.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 28.2% |
| Accounts Receivable | $3.00K | 0.2% |
| Inventory | $633.00K | 45.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Guided Therapeutics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guided Therapeutics Inc's current assets represent 86.9% of total assets in 2024, an increase from 60.7% in 2017.
- Cash Position: Cash and equivalents constituted 28.2% of total assets in 2024, up from 0.2% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 45.9% of total assets.
Guided Therapeutics Inc Competitors by Total Assets
Key competitors of Guided Therapeutics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Guided Therapeutics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Guided Therapeutics Inc generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Guided Therapeutics Inc is currently not profitable relative to its asset base.
Guided Therapeutics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.17 | 0.10 |
| Quick Ratio | 0.03 | 0.07 | 0.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.67 Million | $ -4.98 Million | $ -8.07 Million |
Guided Therapeutics Inc - Advanced Valuation Insights
This section examines the relationship between Guided Therapeutics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.58 |
| Asset Growth Rate (YoY) | -17.4% |
| Total Assets | $1.38 Million |
| Market Capitalization | $2.17 Million USD |
Valuation Analysis
Above Book Valuation: The market values Guided Therapeutics Inc's assets above their book value (1.58 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Guided Therapeutics Inc's assets decreased by 17.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guided Therapeutics Inc (2017–2024)
The table below shows the annual total assets of Guided Therapeutics Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.38 Million | -17.44% |
| 2023-12-31 | $1.67 Million | -50.42% |
| 2022-12-31 | $3.37 Million | +65.00% |
| 2021-12-31 | $2.04 Million | +51.11% |
| 2020-12-31 | $1.35 Million | +14.41% |
| 2019-12-31 | $1.18 Million | +400.00% |
| 2018-12-31 | $236.00K | -51.74% |
| 2017-12-31 | $489.00K | -- |